Philip A. Downing
About Philip A. Downing
Philip A. Downing serves as the Senior Vice President of Nonclinical Services at Inotiv, a position he has held since 2017. He has extensive experience in the pharmaceutical industry, having worked in various roles at BASi and Covance over a career that spans more than two decades.
Current Role at Inotiv
Philip A. Downing serves as the Senior Vice President of Nonclinical Services at Inotiv. He has held this position since 2017, contributing to the company's focus on providing comprehensive nonclinical services. His role involves overseeing various aspects of nonclinical research and development, ensuring that the services meet industry standards and client needs.
Previous Experience at BASi
Philip A. Downing has extensive experience at BASi, where he held multiple roles over a span of 14 years. He began as an Analytical Chemist from 1997 to 1999, then progressed to Manager of Analytical Services from 1999 to 2004. He continued to advance his career at BASi, serving as Director of Analytical Services from 2004 to 2007, and later as Assistant General Manager/Director of Analytical Services from 2007 to 2011. He also held the position of Senior Director of Preclinical Services from 2011 to 2015, before transitioning to Vice President of Preclinical Services until 2017.
Experience at Covance
Prior to his tenure at BASi, Philip A. Downing worked at Covance (GFi Pharmaceuticals) from 1994 to 2001. He started as an Analytical Scientist from 1994 to 1997 and later served as a Radiation Safety Officer from 1996 to 2001. His experience at Covance contributed to his expertise in analytical chemistry and safety protocols within the pharmaceutical industry.
Education and Academic Background
Philip A. Downing studied at Indiana University Bloomington, where he earned a Bachelor of Arts degree in Chemistry and Biology. His academic journey spanned from 1988 to 1993. He also has educational roots in Boonville, which contributed to his foundational knowledge in the sciences.